Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Times of India
The Times of India
Lifestyle
TOI Lifestyle Desk | etimes.in

New Covid vaccines targeting KP.2 variant approved; 5 things to know

As the summer wave, dominated by FlirT variants, takes over the United States, The Food and Drug Administration has approved updated Covid-19 vaccines that specifically target recent variant of the disease - KP.2.

The vaccines made by Pfizer (PFE.N), and Moderna (MRNA.O), to be given for 6 months and above population, will be available in the coming days to enable people to fight the current variants of Covid-19. The new shots are expected to provide relief to the high-risk group at risk of hospitalization and death from the new strains in circulation.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.